Package 0185-0022-01

Brand: orphenadrine citrate

Generic: orphenadrine citrate
NDC Package

Package Facts

Identity

Package NDC 0185-0022-01
Digits Only 0185002201
Product NDC 0185-0022
Description

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0185-0022-01)

Marketing

Marketing Status
Discontinued 2027-03-20
Brand orphenadrine citrate
Generic orphenadrine citrate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "de0e8cdb-788a-4ebe-969d-14d44a14ddc2", "openfda": {"unii": ["X0A40N8I4S"], "rxcui": ["994521"], "spl_set_id": ["239018ff-cec6-46de-ae9d-26c9ec034a32"], "manufacturer_name": ["Sandoz Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0185-0022-01)", "package_ndc": "0185-0022-01", "marketing_end_date": "20270320", "marketing_start_date": "20000215"}], "brand_name": "Orphenadrine Citrate", "product_id": "0185-0022_de0e8cdb-788a-4ebe-969d-14d44a14ddc2", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "0185-0022", "generic_name": "Orphenadrine Citrate", "labeler_name": "Sandoz Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Orphenadrine Citrate", "active_ingredients": [{"name": "ORPHENADRINE CITRATE", "strength": "100 mg/1"}], "application_number": "ANDA040327", "marketing_category": "ANDA", "marketing_end_date": "20270320", "marketing_start_date": "20000215"}